TET1 and B-cell non-Hodgkin lymphoma: In additional studies, mice with a combined Tet2- and Tet3-deficiency in developing B cells developed B cell lymphoma and succumbed to disease within 5–6 months of age, much earlier than the 15–20 months observed in Tet1/Tet2-deficient mice (159, 160).